Cytokinetics
Manufacturing · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
350 Oyster Point Blvd, South San Francis...Phone Number
(650) 624-3000Website
www.cytokinetics.comRevenue
$105.8 MillionStock Symbol
CYTKIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
1
2
1
1
About Cytokinetics
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Founded in South San Francisco, California, by pioneers in the field of muscle biology, we have been leveraging our scientific expertise to develop new medicines for patients.Explore more
Cytokinetics Org Chart
JC
Global Executive Director, Supply Chain
JV
Head Senior Director, Chemical Development & ...
BL
Head Senior Director, Regulatory Labeling
BP
Senior Director, Trade & Distribution
JB
Senior Director, Project Management
CB
Senior Director, Facilities EH & S
IK
Director, Program Management
KC
Director
DX
Associate Director
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytokinetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cytokinetics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cytokinetics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cytokinetics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cytokinetics
Product Launch: Get notified when Cytokinetics launches new products
Earning: See what the market has to say on Cytokinetics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Cytokinetics is spiking on competitors!
Funding: Get notified immidiatlly once Cytokinetics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cytokinetics
Compare insights from companies similar to Cytokinetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cytokinetics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cytokinetics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cytokinetics.
Cytokinetics financials insights
Gather financial insights about Cytokinetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Stock Offering
$89.7M
2006
Stock Offering
$33M
2017
Other Financing Round
$100M
Cytokinetics Tech Stack
A closer look at the technologies used by Cytokinetics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Cytokinetics News & Media
Cytokinetics (CYTK) Launches MYQORZO in Germany for Obstructive HCM Treatment
Cytokinetics (NASDAQ:CYTK) is one of the most promising mid-cap stocks to buy according to analysts. On June 1, Cytokinetics announced the first commercial European launch of MYQORZO (aficamten) in Germany for the treatment of symptomatic obstructive hypertrophic cardiomyopathy/oHCM. The launch follows European Commission approval in February and builds on prior regulatory approvals in the US […]Cytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Cytokinetics, Incorporated (CYTK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 9:18 AM EDTCompany ParticipantsRobert I.Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
Program to Provide Donations to Non-Profit Organizations Aligned with Corporate ValuesCytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
European Launch Follows Strong U.S. Start
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytokinetics
Sign Up For FreeTo access detailed company insights
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Founded in South San Francisco, California, by pioneers in... Read More
